Discovery of the first non-ATP competitive IGF-1R kinase inhibitors: Advantages in comparison with competitive inhibitors
Lesuisse, D., Mauger, J., Nemecek, C., Maignan, S., Boiziau, J., Harlow, G., Hittinger, A., Ruf, S., Strobel, H., Nair, A., Ritter, K., Malleron, J.L., Dagallier, A., El-Ahmad, Y., Guilloteau, J.P., Guizani, H., Bouchard, H., Venot, C.(2011) Bioorg Med Chem Lett 21: 2224-2228
- PubMed: 21441024 
- DOI: https://doi.org/10.1016/j.bmcl.2011.03.003
- Primary Citation of Related Structures:  
3O23 - PubMed Abstract: 
A new series of IGF-1R inhibitors related to hydantoins were identified from a lead originating from HTS. Their noncompetitive property as well as their slow binding characteristics provided a series of compounds with unique selectivity and excellent cellular activities.
Organizational Affiliation: 
Medicinal Chemistry, Sanofi-aventis, 13 Quai Jules Guesde, 94300 Vitry-sur-Seine, France. dominique.lesuisse@sanofi-aventis.com